WTF: Arovella Therapeutics
Arovella Therapeutic’s CEO reveals what iNKT cell therapies are, how they work and why they are promising for cancer treatment.
Arovella Therapeutic’s CEO reveals what iNKT cell therapies are, how they work and why they are promising for cancer treatment.
Tony Locantro returns to the desk after a pit stop in Sanur, Indonesia, where he has learned the art of riding the quarterly wave.
The big resources winners in April were looking for gold, copper and rare earths, with DY6 taking top spot for biggest monthly stock gain.
The ASX broke a more than week-long winning streak to fall across the board today, losing almost a full percentage point with particular weakness in the Energy and Financials sectors.
Akora Resources’ Bekisopa iron ore project is highly prospective for DSO mineralisation and the release of a pre-feasibility study is imminent.
Trump’s tariffs are rocking the market, but Morningstar’s Lochlan Halloway says focus on fundamentals and avoid panic selling.
Shares in Caprice Resources more than doubled after the company reported recent high-grade gold hits from its Island gold project. Kristie Batten explores.
The ASX bounced back on Friday, with miners driving the rally. US shutdown fears eased and Myer and Liontown had a solid run.
The ASX has grabbed some welcome relief at lunch, thanks to the efforts of local miners. Can it last into the weekend?
The closure by Alphamin of a mine in the DRC has seen tin prices jump to eight-month highs of US$34,815 a tonne.
Omega Oil and Gas will continue flow testing of its Canyon-1H horizontal well in Queensland’s Taroom Trough for approximately30 days to establish reservoir performance.
Gold prices crashed through another all-time high, and there’s a good chance things could get better as rate cuts materialise.
Original URL: https://www.couriermail.com.au/business/stockhead/page/192